share_log

HC Wainwright & Co. Reiterates Buy on Biotricity, Raises Price Target to $4

HC Wainwright & Co. Reiterates Buy on Biotricity, Raises Price Target to $4

HC Wainwright & Co.重申对 Biotricity 的买入,将目标股价提高至 4 美元
Benzinga ·  2023/07/05 07:26

HC Wainwright & Co. analyst Kevin Dede reiterates Biotricity (NASDAQ:BTCY) with a Buy and raises the price target from $2 to $4.

HC Wainwright&Co.分析师凯文·迪德重申了纳斯达克(BTCY)的买入计划,并将目标价从2美元上调至4美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发